Crossmark

Assessment of priorities, quality, and inclusivity of digital therapeutics trials in China

Published Online: 2025-02-04

Authors

Wang, Ziming

Xia, Xinxin

Lu, Weijia

Ye, Yuguo

Xu, Jin
License Information

Text and Data Mining valid from 2025-02-04

Version of Record valid from 2025-02-04
More Information

Article History

Received: 8 October 2024

Accepted: 24 January 2025

First Online: 4 February 2025

Competing interests

: The authors declare no competing interests.

Document is current